These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 17064713)

  • 1. Discontinuous and continuous separation of the monomeric and dimeric forms of human bone morphogenetic protein-2 from renaturation batches.
    Gueorguieva L; Vallejo LF; Rinas U; Seidel-Morgenstern A
    J Chromatogr A; 2006 Dec; 1135(2):142-50. PubMed ID: 17064713
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Step gradients in 3-zone simulated moving bed chromatography. Application to the purification of antibodies and bone morphogenetic protein-2.
    Kessler LC; Gueorguieva L; Rinas U; Seidel-Morgenstern A
    J Chromatogr A; 2007 Dec; 1176(1-2):69-78. PubMed ID: 18036537
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Optimized procedure for renaturation of recombinant human bone morphogenetic protein-2 at high protein concentration.
    Vallejo LF; Rinas U
    Biotechnol Bioeng; 2004 Mar; 85(6):601-9. PubMed ID: 14966801
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Expression, purification, and renaturation of bone morphogenetic protein-2 from Escherichia coli.
    Long S; Truong L; Bennett K; Phillips A; Wong-Staal F; Ma H
    Protein Expr Purif; 2006 Apr; 46(2):374-8. PubMed ID: 16298141
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Expression and purification of biologically active rat bone morphogenetic protein-4 produced as inclusion bodies in recombinant Escherichia coli.
    Klösch B; Fürst W; Kneidinger R; Schuller M; Rupp B; Banerjee A; Redl H
    Biotechnol Lett; 2005 Oct; 27(20):1559-64. PubMed ID: 16245174
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Expression, purification, and refolding of a recombinant human bone morphogenetic protein 2 in vitro.
    Zhang Y; Ma Y; Yang M; Min S; Yao J; Zhu L
    Protein Expr Purif; 2011 Feb; 75(2):155-60. PubMed ID: 20691269
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Renaturation and purification of bone morphogenetic protein-2 produced as inclusion bodies in high-cell-density cultures of recombinant Escherichia coli.
    Vallejo LF; Brokelmann M; Marten S; Trappe S; Cabrera-Crespo J; Hoffmann A; Gross G; Weich HA; Rinas U
    J Biotechnol; 2002 Mar; 94(2):185-94. PubMed ID: 11796171
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Expression and purification of recombinant bone morphogenetic protein-2 in E.coli.
    Xiong SH; Yu L; Tan HY; Huang T; Wang CY; Liu DY; Zhong SZ
    Di Yi Jun Yi Da Xue Xue Bao; 2002 May; 22(5):413-6. PubMed ID: 12390700
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Development of an enzyme-linked immunoreceptor assay (ELIRA) for quantification of the biological activity of recombinant human bone morphogenetic protein-2.
    Wendler J; Hoffmann A; Gross G; Weich HA; Bilitewski U
    J Biotechnol; 2005 Oct; 119(4):425-35. PubMed ID: 15993504
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A novel TWO-STEP renaturation procedure for efficient production of recombinant BMP-2.
    von Einem S; Schwarz E; Rudolph R
    Protein Expr Purif; 2010 Sep; 73(1):65-9. PubMed ID: 20302941
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The effects of recombinant human bone morphogenetic protein-2, recombinant human bone morphogenetic protein-12, and adenoviral bone morphogenetic protein-12 on matrix synthesis in human annulus fibrosis and nucleus pulposus cells.
    Gilbertson L; Ahn SH; Teng PN; Studer RK; Niyibizi C; Kang JD
    Spine J; 2008; 8(3):449-56. PubMed ID: 18455111
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Bone formation zones in heterotopic ossifications: histologic findings and increased expression of bone morphogenetic protein 2 and transforming growth factors beta2 and beta3.
    Toom A; Arend A; Gunnarsson D; Ulfsparre R; Suutre S; Haviko T; Selstam G
    Calcif Tissue Int; 2007 Apr; 80(4):259-67. PubMed ID: 17401695
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Application of BMP to bone repair].
    Yamaguchi A
    Clin Calcium; 2007 Feb; 17(2):263-9. PubMed ID: 17272885
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Optimized procedure for expression and renaturation of recombinant human bone morphogenetic protein-2 at high protein concentrations.
    Zhang H; Wu J; Zhang Y; Fu N; Wang J; Zhao S
    Mol Biol Rep; 2010 Oct; 37(7):3089-95. PubMed ID: 19823948
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Production of the recombinant human bone morphogenetic protein-2 in Escherichia coli and testing of its biological activity in vitro and in vivo].
    Sharapova NE; Kotnova AP; Galushkina ZM; Lavrova NV; Poletaeva NN; Tukhvatulin AE; Semikhin AS; Gromov AV; Soboleva LA; Ershova AS; Zaĭtsev VV; Sergienko OV; Lunin VG; Kariagina AS
    Mol Biol (Mosk); 2010; 44(6):1036-44. PubMed ID: 21290825
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Type I receptor binding of bone morphogenetic protein 6 is dependent on N-glycosylation of the ligand.
    Saremba S; Nickel J; Seher A; Kotzsch A; Sebald W; Mueller TD
    FEBS J; 2008 Jan; 275(1):172-83. PubMed ID: 18070108
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Application of an SPR-based receptor assay for the determination of biologically active recombinant bone morphogenetic protein-2.
    Wendler J; Vallejo LF; Rinas U; Bilitewski U
    Anal Bioanal Chem; 2005 Mar; 381(5):1056-64. PubMed ID: 15744518
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Recombinant protein purification using gradient assisted simulated moving bed hydrophobic interaction chromatography. Part II: process design and experimental validation.
    Gueorguieva L; Palani S; Rinas U; Jayaraman G; Seidel-Morgenstern A
    J Chromatogr A; 2011 Sep; 1218(37):6402-11. PubMed ID: 21824621
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Production of human recombinant bone morphogenetic protein-2A by high density culture of Escherichia coli with stationary dissolved oxygen fed-batch condition.
    Li M; Chen C; Pu Q; Chen S
    Chin J Biotechnol; 1998; 14(3):157-63. PubMed ID: 10503075
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Bone formation on apatite-coated titanium incorporated with bone morphogenetic protein and heparin.
    Kodama T; Goto T; Miyazaki T; Takahashi T
    Int J Oral Maxillofac Implants; 2008; 23(6):1013-9. PubMed ID: 19216269
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.